Patent: 8,809,562
✉ Email this page to a colleague
Summary for Patent: 8,809,562
Title: | Use of metallocene compounds for cancer treatment |
Abstract: | Metallocene compounds and pharmaceutical compositions containing these metallocene compounds are disclosed and described. Methods of treating cancer employing such metallocene compounds and pharmaceutical compositions also are provided. |
Inventor(s): | Hlavinka; Mark L. (Bartlesville, OK), Yang; Qing (Bartlesville, OK), Murph; Mandi Michelle (Watkinsville, GA) |
Assignee: | Chevron Phillips Chemical Company LP (The Woodlands, TX) |
Application Number: | 13/488,490 |
Patent Claims: | see list of patent claims |
Details for Patent 8,809,562
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Teknika Llc | TICE BCG | bcg live | For Injection | 102821 | 06/21/1989 | ⤷ Try a Trial | 2031-06-06 |
Genentech, Inc. | RITUXAN | rituximab | Injection | 103705 | 11/26/1997 | ⤷ Try a Trial | 2031-06-06 |
Idec Pharmaceuticals Corp. | RITUXAN | rituximab | Injection | 103737 | 02/19/2002 | ⤷ Try a Trial | 2031-06-06 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | ⤷ Try a Trial | 2031-06-06 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |